Jane Street Group, LLC Chembio Diagnostics, Inc. Transaction History

Jane Street Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.25 - $0.45 $3,489 - $6,281	13,958 Added 64.36%	35,646 $15,000
Q4 2022 Feb 14, 2023	BUY	$0.2 - $0.33 $4,337 - $7,157	21,688 New	21,688 $4,000
Q2 2022 Aug 16, 2022	SELL	$0.45 - $0.8 $3,079 - $5,474	-6,843 Reduced 23.34%	22,472 $15,000
Q1 2022 May 17, 2022	BUY	$0.66 - $1.23 $3,896 - $7,261	5,904 Added 25.22%	29,315 $24,000
Q4 2021 Feb 15, 2022	SELL	$1.09 - $2.55 $25,163 - $58,869	-23,086 Reduced 49.65%	23,411 $27,000
Q3 2021 Nov 16, 2021	BUY	$2.06 - $5.34 $75,078 - $194,621	36,446 Added 362.61%	46,497 $116,000
Q2 2021 Aug 16, 2021	SELL	$2.88 - $5.64 $3,090 - $6,051	-1,073 Reduced 9.65%	10,051 $29,000
Q1 2021 May 18, 2021	SELL	$3.4 - $7.97 $15,935 - $37,355	-4,687 Reduced 29.64%	11,124 $39,000
Q4 2020 Feb 17, 2021	SELL	$4.11 - $7.51 $56,787 - $103,765	-13,817 Reduced 46.63%	15,811 $75,000
Q3 2020 Nov 17, 2020	SELL	$3.28 - $5.93 $112,979 - $204,258	-34,445 Reduced 53.76%	29,628 $144,000
Q2 2020 Aug 17, 2020	BUY	$3.18 - $15.54 $146,260 - $714,746	45,994 Added 254.41%	64,073 $208,000
Q1 2020 May 15, 2020	BUY	$2.36 - $5.6 $42,666 - $101,242	18,079 New	18,079 $93,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.